Evaluation for quality of serious adverse intrauterine device event case reports and analysis of related factors
YANG Yuehua1,2 ZHOU Jian1,2 SHI Wenhui1,2 ZHANG Min1,2 XU Haoqin1,2▲ HANG Guifang3▲
1.State Contraceptives Adverse Reaction Surveillance Center, Jiangsu Province, Nanjing 210036, China;
2.Jiangsu Institute of Planned Parenthood Research, Jiangsu Province, Nanjing 210036, China;
3.Department of Ultrasound Integrated Traditional Chinese and Western Hospital in Jiangsu, Jiangsu Province, Nanjing 210028, China
Abstract：Objective To evaluate the quality of the reports of serious adverse intrauterine device event, and seek the influencing factors in order to further improve the quality of reports. Methods According to the quality assessment standards made by Center for Drug Revaluation of CFDA, 263 case reports collected during the period from July 2016 to June 2017 were evaluated, and the scores of each report were input to a database built by Epidata 3.1 and analyzed by SPSS 19.0 software. Results The quality of the reports was generally good. Missing or filling in a mistake of those items such as time limit, impact on the patient, product number or batch number, production date caused subtraction mainly. The monitoring site category, medical data supported, adverse event were all have significant effects on the quality of reports (P ＜ 0.01). Conclusion Governors and rapporteurs should pay more attention to the problems identified in the evaluation and further improve the quality of reports pertinently.
杨月华1,2 周健1,2 施雯慧1,2 张敏1,2 许豪勤1,2▲ 杭桂芳3▲. 宫内节育器严重伤害事件报告质量评估及影响因素分析[J]. 中国医药导报, 2018, 15(8): 129-133.
YANG Yuehua1,2 ZHOU Jian1,2 SHI Wenhui1,2 ZHANG Min1,2 XU Haoqin1,2▲ HANG Guifang3▲. Evaluation for quality of serious adverse intrauterine device event case reports and analysis of related factors. 中国医药导报, 2018, 15(8): 129-133.
[1] Kumar A. Pharmacovigilance：importance，concepts，and processes [J]. Am J Health Syst Pharm，2017，74（8）：e101-e107.
[2] 田月洁，李泮海，谢彦军，等.医疗器械不良事件报告质量控制的实践与探讨[J].中国药物警戒，2011，08（11）：651-653.
[3] van Puijenbroek E，Conemans J，van Grootheest K. Spontaneous ADR reports as a trigger for pharmacogenetic research：a prospective observational study in the Netherlands [J]. Drug Safety，2009，32（3）：255-264.
[4] 黄琳，赵玉娟，田月洁.医疗器械严重伤害事件分析评价方法的探讨[J].中国医疗设备，2015，30（8）：130-132.
[5] 李瑛，张世琨，张黎明，等.全国避孕药具不良反应监测试点数据初步分析[J].中国计划生育学杂志，2012，20（10）：660-663.
[6] 国家食品药品监督管理总局药品评价中心，国家药品不良反应监测中心.医疗器械不良事件报告表质量评估规定（试行）[Z].2016.
[7] Didry P，Lapp A. Adverse event sheets，a quality improvement tool [J]. Rev Infirm，2017，66（231）：28-29.
[8] Ribeiro A，Lima S，Zampieri ME，et al. Filling quality of the reports of adverse drug reactions received at the Pharmacovigilance Centre of S?覿o Paulo （Brazil）：missing information hinders the analysis of suspected associations [J]. Expert Opin Drug Saf，2017，16（12）：1329-1334.
[9] 国家食品药品监督管理局，中华人民共和国卫生部.医疗器械不良事件监测和再评价管理办法（试行）[Z].2008.
[10] 申素琪，李瑛. 90例宫内节育器异位不良事件报告分析[J].中国计划生育学杂志，2010，18（2）：111-113.
[11] 廖革红.32例异位妊娠误诊分析[J].中国医药导报，2006， 3（3）：119.
[12] 伍欣.宫内节育器异位80例临床分析[D].长春：吉林大学，2012.
[13] 潘光华，陈湘华.异位妊娠236例临床分析[J].中国医药导报，2009，6（25）：159-160.
[14] 董延磊，朱琳.腹腔镜在异位妊娠诊治中的应用[J].腹腔镜外科杂志，2016（6）：407-408.
[15] 王玲，周晶鑫，张学宁，等. 医疗器械不良事件报告数据规整实践与提升报告质量的探索[J]. 中国医疗器械杂志，2014（5）：364-367.
[16] 黄晓玲，陈英耀，何露洋，等.美国、欧盟与我国医疗器械不良事件监测体系比较研究[J].中国卫生质量管理，2017，24（2）：90-93.
[17] Terblanche A，Meyer JC，Godman B，et al. Knowledge，attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa：baseline analysis [J]. Hospital Practice，2017，45（5）：238-245.
[18] Linder JA，Haas JS，Iyer A，et al. Secondary use of electronic health record data：spontaneous triggered adverse drug event reporting [J]. Pharmacoepidemiology & Drug Safety，2010，19（12）：1211.
[19] Salverda JGW，Bragt PJC，De Wit-Bos L，et al. Results of a cosmetovigilance survey in the Netherlands [J]. Contact Dermatitis，2013，68（3）：139-148.
2018, Vol. 15 
京公网安备 11010502046598号